Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ji-Quan Fan"'
Autor:
Gang Wu, Fang Zhu, Rui-Guang Zhang, Zhen-Yu Li, Jing Chen, Jing-Hua Ren, Li-Ling Zhang, Ji-Quan Fan, Xian-Yi Cai, Yun Xia
B16 cells were seeded in 96-well plates and incubated with various concentrations of fasudil for 24h. The cell inhibitory rate was measured using an MTT assay. Fasudil inhibited B16 cell proliferation in a dose-dependent manner, and the IC50 for 24h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::176b754e49f22f07be55322e0badafce
https://doi.org/10.1158/1535-7163.22502356.v1
https://doi.org/10.1158/1535-7163.22502356.v1
Autor:
Gang Wu, Fang Zhu, Rui-Guang Zhang, Zhen-Yu Li, Jing Chen, Jing-Hua Ren, Li-Ling Zhang, Ji-Quan Fan, Xian-Yi Cai, Yun Xia
(A) HE staining of tissue section. A vessel formed with elongated endothelial cells was showed by a red arrow, moreover, the vessel lack of endothelial cells nearby was pointed out by a yellow arrow. Original magnification, ×400. (B) Plenty of bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93b9efbd135c26d8ccf911b31438fd18
https://doi.org/10.1158/1535-7163.22502353.v1
https://doi.org/10.1158/1535-7163.22502353.v1
Publikováno v:
Medicine
Background: Adjuvant trastuzumab improves survival outcomes of human epidermal receptor 2 positive early breast cancer patients. Currently, administration of 12 months adjuvant trastuzumab is the standard therapy. However, whether 6 months treatment
Autor:
Jinghua Ren, Fang Zhu, Gang Wu, Ji-Quan Fan, Xian-Yi Cai, Yun Xia, Ruiguang Zhang, Liling Zhang, Zhenyu Li
Publikováno v:
International Journal of Cancer. 144:2227-2238
Vasculogenic mimicry (VM) is a special vascular pattern in malignant tumors, which is composed of highly aggressive tumor cells. This tumor cell-mediated blood supply pattern is closely associated with a poor prognosis in cancer patients. The interac
Publikováno v:
Medicine. 99:e21273
BACKGROUND The combination of durvalumab and tremelimumab results in clinical benefit, with a tolerable safety profile in patients with solid tumors. OBJECTIVE To evaluate the efficacy and safety of durvalumab in combination with tremelimumab compare
Autor:
Yun, Xia, Xian-Yi, Cai, Ji-Quan, Fan, Li-Ling, Zhang, Jing-Hua, Ren, Zhen-Yu, Li, Rui-Guang, Zhang, Fang, Zhu, Gang, Wu
Publikováno v:
International journal of cancer. 144(9)
Vasculogenic mimicry (VM) is a special vascular pattern in malignant tumors, which is composed of highly aggressive tumor cells. This tumor cell-mediated blood supply pattern is closely associated with a poor prognosis in cancer patients. The interac
Autor:
Bi-Cheng Wang, Bo-Ya Xiao, Ji-Quan Fan, Guo-He Lin, Chang Wang, Quentin Liu, Yan-Xia Zhao, Wang, Bi-Cheng, Xiao, Bo-Ya, Fan, Ji-Quan, Lin, Guo-He, Wang, Chang, Liu, Quentin, Zhao, Yan-Xia
Publikováno v:
Medicine; 3/12/2021, Vol. 100 Issue 10, p1-7, 7p
Publikováno v:
Anti-cancer drugs. 28(5)
GTPase RhoA and its downstream Rho-associated coiled-coil-containing protein kinases (ROCKs) are frequently overexpressed in human cancers. Inhibition of the RhoA/ROCK pathway blocks angiogenesis mediated by the vascular endothelial growth factor, wh
Autor:
Bi-Cheng Wang, Peng-Cheng Li, Ji-Quan Fan, Guo-He Lin, Quentin Liu, Wang, Bi-Cheng, Li, Peng-Cheng, Fan, Ji-Quan, Lin, Guo-He, Liu, Quentin
Publikováno v:
Medicine; 7/10/2020, Vol. 99 Issue 28, p1-11, 11p
Autor:
Yun Xia, Fang Zhu, Zhenyu Li, Jinghua Ren, Xian-Yi Cai, Jing Chen, Gang Wu, Ruiguang Zhang, Liling Zhang, Ji-Quan Fan
Publikováno v:
Molecular cancer therapeutics. 14(7)
The aim of this study was to investigate the biologic role of the Rho kinase inhibitor fasudil in the vasculogenic mimicry (VM) of B16 mouse melanoma cells. It was previously reported that RhoA plays a critical role in angiogenesis by coordinating en